Inflammasomes are multiprotein platforms that activate caspase-1, which leads to the processing and secretion of the proinflammatory cytokines IL-1β and IL-18. Previous studies demonstrated that bacterial RNAs activate the nucleotide-binding domain, leucine-rich-repeatcontaining family, pyrin domain-containing 3 (NLRP3) inflammasome in both human and murine macrophages. Interestingly, only mRNA, but neither tRNA nor rRNAs, derived from bacteria could activate the murine Nlrp3 inflammasome. Here, we report that all three types of bacterially derived RNA (mRNA, tRNA, and rRNAs) were capable of activating the NLRP3 inflammasome in human macrophages. Bacterial RNA's 5′-end triphosphate moieties, secondary structure, and double-stranded structure were dispensable; small fragments of bacterial RNA were sufficient to activate the inflammasome. In addition, we also found that 20-guanosine ssRNA can activate the NLRP3 inflammasome in human macrophages but not in murine macrophages. Therefore, human and murine macrophages may have evolved to recognize bacterial cytosolic RNA differently during bacterial infections.
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bacterial RNA | single-stranded RNA | NLRP3 inflammasome | innate immunity | primary macrophages T he innate immune system is the first line of defense against microbial infections. Germ-line-encoded pattern-recognition receptors (PRRs) of the innate immune system recognize the presence of invariant evolutionarily conserved microbial components called "pathogen-associated molecular patterns" (1) (2) (3) . In response to microbial infections, PRRs rapidly initiate signaltransduction pathways to induce type 1 IFN production, proinflammatory cytokine production, and inflammasome activation. The inflammasome is a cytosolic large caspase-1-containing multiprotein complex that enables autocatalytic activation of caspase-1. Once caspase-1 is activated, it starts to cleave prointerleukin-1β (pro-IL-1β) and prointerleukin-18 (pro-IL-18) proteolytically into bioactive IL-1β and IL-18 (4-7). The mature forms of IL-1β and IL-18 play roles in a variety of infectious and inflammatory processes.
Cytosolic microbial nucleic acids are important activators of the innate immune system against both bacterial and viral infections, which induce type 1-IFN and proinflammatory cytokine responses as well as inflammasome activation. The role of microbial nucleic acids in inflammasome activation has been studied mostly in murine bone marrow-derived dendritic cells (BMDCs) or bone marrow-derived macrophages (BMDMs). AIM2 has been identified as a specific cytosolic dsDNA sensor that directly binds ASC (apoptosis-associated speck-like protein containing a carboxyl-terminal CARD-like domain) and forms inflammasome complexes in human and murine cells (8) (9) (10) (11) .
Viral dsRNA was found to activate the nucleotide-binding domain, leucine-rich-repeat-containing family, pyrin domaincontaining 3 (NLRP3) inflammasome in human and murine cells (12) (13) (14) (15) . Several groups have reported that cytosolic bacterial RNA activate the Nlrp3 inflammasome in murine macrophages (13, 16, 17) . Our group also has reported that human THP-1-derived macrophages recognize cytosolic bacterial RNA and induce NLRP3 inflammasome activation (12) . Bacterial RNA is composed of mRNA, tRNA, and three different sizes of rRNA (23s, 16s, and 5s). Sander et al. (18) reported that, of the different types of Escherichia coli RNA, only E. coli mRNA induced the secretion of IL-1β by murine BMDMs, but E. coli tRNA and E. coli rRNAs did not.
We aimed to study (i) whether a variety of cytosolic bacterial RNAs could activate the inflammasome in human myeloid cells and (ii) what types of bacterial RNA activate the inflammasome in human and murine myeloid cells. Here, we demonstrate that a broad spectrum of cytosolic bacterial RNAs strongly induce the cleavage of caspase-1 and the secretion of IL-1β and IL-18 in human macrophages. Human macrophages can sense mRNA, tRNA, rRNAs, and small synthetic ssRNA through NLRP3, but murine macrophages can sense only the mRNA component. Bacterial RNA's 5′-end triphosphate moieties, secondary structure, and double-stranded structure were dispensable, but small fragments of bacterial RNA were sufficient to activate the inflammasome. These findings suggest that upon bacterial infections the human and murine NLRP3 inflammasomes sense cytosolic bacterial RNAs differently.
Significance
The innate immune system has evolved to protect the host from potential pathogens. The nucleotide-binding domain, leucine-rich-repeat-containing family, pyrin domain-containing 3 (NLRP3) inflammasome is one of the platforms that can sense pathogenic bacteria, which can cause fatal bacterial infections. Here we show that all three types of bacteria-derived RNAmRNA, tRNA, and rRNAs-as well as synthetic 20-guanosine ssRNA, are capable of activating the NLRP3 inflammasome and inducing human macrophages to secrete inflammatory cytokines. Interestingly, only bacterial mRNA is able to activate the murine Nlrp3 inflammasome. Therefore human macrophages may have evolved in a unique fashion, adapting to the bacterial environment. This study could provide important clues for developing efficient medicines for bacterial infections and various immunotherapies such as anticancer vaccines.
Results
Cytosolic Gram-Negative and Gram-Positive Bacterial RNAs Induce Inflammasome Activation in Human Macrophages. To investigate whether bacterial RNAs induce inflammasome activation in human macrophages, we purified RNA from various kinds of Gram-negative and Gram-positive bacteria, including bacteria that can cause human infectious diseases. We first stimulated primary human monocyte-derived macrophages (MDMs) with these bacterial RNAs with or without Lipofectamine 2000 (L2K). The phenotype of primary human macrophages was tested by human macrophage markers CD14 and CD33 by flow cytometry (Fig. S1A) , and the morphology of the human MDMs was observed under an electron microscope. We found that all types of bacterial RNAs that were transfected with L2K led to the secretion of IL-1β and IL-18 (Fig. 1A) in human MDMs. On the other hand, bacterial RNAs without L2K did not induce secretion of IL-1β or IL-18 (Fig. 1A) , indicating that bacterial RNAs are recognized in the cytosol. As in human primary macrophages, all tested bacterial total RNA induced inflammasome activation in phorbol 12-myristate 13-acetate (PMA)-differentiated human monocytic THP-1 cells (THP-1-derived macrophages) (Fig.  S2A) . Secretion of IL-1β and IL-18 induced by L2K-transfected bacterial RNAs was abolished almost completely in primary human MDMs (Fig. 1B) and THP-1-derived macrophages (Fig.  S2B ) by treatment with an RNase mixture that cleaves the 3′ end of ssRNA, indicating that inflammasome activation is indeed mediated by RNA but not by potential contamination of other bacterial components. Because E. coli total RNA is the beststudied bacterial RNA in murine macrophages, we decided to focus on E. coli total RNA in human macrophages for further analysis. E. coli total RNA with L2K induced IL-1β and IL-18 secretion ( Fig. 2A) and cleavage of IL-1β (p17) and caspase-1 (Casp1) (p20 and p22) (Fig. 2B ) in THP-1-derived macrophages in a dose-dependent manner. To exclude the contamination of DNA further, we treated E. coli total RNA with DNase I or RNase I. DNase I treatment did not affect the ability of E. coli total RNA to induce inflammasome activation ( Fig. 2 C and D) .
These results clearly indicate that cytosolic bacterial RNAs induce inflammasome activation in human macrophages.
All Bacterial RNA Components (mRNA, tRNA, and rRNAs) Induce Inflammasome Activation in Human Macrophages. A previous study showed that, of the various E. coli components, only mRNA could activate the inflammasome in murine BMDMs (18) . To determine which E. coli RNA components promote inflammasome activation in human macrophages, we generated E. coli mRNA, tRNA, 23s rRNA, 16s rRNA, and 5s rRNA by in vitro transcription (Fig. 3A) . The secondary structures for rRNAs and tRNA were predicted by RNAfold WebServer (Fig. S3) , and the purities were confirmed by Agilent Bioanalyzer (Fig. S4A) . We stimulated murine BMDMs and human MDMs with these in vitrotranscribed RNAs and examined the secretion of IL-1β and IL-18 and the cleavage of caspase-1. The phenotype of murine BMDMs was tested by F4/80 and CD11b (Fig. S1B) . In murine BMDMs, we confirmed that only mRNA induced secretion of IL-1β and IL-18 ( Fig. 3B ) and cleavage of caspase-1 (p10) (Fig. 3C) . Similar results were observed in the murine macrophage cell line Raw264.7 (Fig.  S5 ). On the other hand, not only mRNA but also tRNA, 23s rRNA, 16s rRNA, and 5s rRNA led to the secretion of IL-1β and IL-18 and the cleavage of caspase-1 both in primary human MDMs (Fig. 3 D and E) and in THP-1-derived macrophages (Fig. 3 F and G) . In contrast to in vitro-transcribed bacterial RNAs, a synthetic Toll-like receptor 8 (TLR8) ligand, poly U, did not induce inflammasome activation (Fig. 3 F and G), a finding that is similar to a previous report (19) . RNase treatment of in vitro-transcribed bacterial RNAs completely abolished IL-1β and IL-18 secretion (Fig. 3F ), indicating that inflammasome activation is indeed mediated by these RNAs.
To confirm bacterial RNA recognition in human cells further, we isolated native tRNA, 23s rRNA, 16s rRNA, and 5s rRNA from E. coli total RNA via denaturing RNA gel ( Fig. 4 A and B) . We then stimulated THP-1-derived macrophages with individual native E. coli RNA or poly U and examined the secretion of IL-1β and IL-18 and the cleavage of IL-1β and caspase-1. All the GramGram+ GramGram+ native bacterial RNAs tested induced IL-1β and IL-18 secretion (Fig. 4C) and cleavage of IL-1β and caspase-1 (Fig. 4D ), but poly U did not. Therefore we conclude that human macrophages recognize all the individual bacterial RNA components. (20) . Because bacterial RNAs also have 5′-end triphosphate moieties, we next tested whether 5′ triphosphate moieties play a role in inflammasome activation in human macrophages. We stimulated THP-1-derived macrophages with E. coli total RNA pretreated with calf intestinal alkaline phosphatase (CIP), which removes the 5′-end triphosphate moieties. CIP treatment did not affect E. coli RNA-induced IL-1β and IL-18 secretion (Fig. 5A ), indicating that 5′-end triphosphate moieties are not required for bacterial RNA-induced inflammasome activation. We next tested the length of RNA required for the inflammasome activation. RNA fragmentation reagents were used to fragment RNA into 60-200 nucleotides. E. coli total RNA-induced IL-1β and IL-18 secretion was not altered by treatment with RNA fragmentation reagents (Fig. 5A ). RNase III digests dsRNA into small 12-to 15-base fragments. E. coli mRNA, tRNA, and rRNAs form short double-stranded stems and were digested into small fragments by treatment with RNase III (Fig. 5B ). In contrast to RNase A or RNase I treatment, the treatment with RNase III did not affect secretion of IL-1β and IL-18 or cleavage of IL-1β and caspase-1 ( Fig. 5 C and D) , suggesting that the double-stranded structure of bacterial RNA is not required. RNA poly I:C is well known to induce NLRP3 inflammasome activation in both human and murine macrophages. To investigate further whether dsRNA structures are necessary for the inflammasome activation that is induced by bacterial RNA, we heat-denatured E. coli total RNA and the double-stranded RNA analog poly I:C to disrupt the double-stranded structure. We stimulated THP-1-derived macrophages with poly I:C or E. coli total RNA with or without heat denaturation. As previously reported, poly I:C-induced IL-1β and IL-18 secretion was abrogated completely by heat denaturation of RNA in THP-1-derived macrophages (Fig. 5E) . In contrast to poly I:C, heat-denatured E. coli total RNA led to similar amounts of IL-1β and IL-18 secretion compared with untreated RNA in THP-1-derived macrophages (Fig. 5E ). In addition, 5s short rRNA (5s short) consisting of 1-47 bases, which does not contain complementary sequences to form a double-stranded stem, also induces secretion of IL-1β and IL-18 in THP-1-derived macrophages (Fig. 5F ). These results suggest that 5′-end triphosphate moieties, the full-length intact secondary structure, and the double-stranded structure of bacterial RNA are (B and C) Murine BMDMs were primed with 100 ng/mL LPS for 3 h and then were stimulated with E. coli total RNA or in vitro-transcribed RNAs plus L2K for 16 h. Culture supernatants were analyzed for IL-1β and IL-18 by ELISA (B) and for cleavage of caspase-1 (p10) by immunoblotting (C). Cell lysates were analyzed for procaspase-1 and β-actin (C). NS, nonspecific band. (D and E) Human MDMs were stimulated with E. coli total RNA or in vitro-transcribed RNAs plus L2K. Cell supernatants were analyzed for IL-1β and IL-18 by ELISA (D) and for cleavage of IL-1β and caspase-1 (p20) by immunoblotting (E). Cell lysates were analyzed for pro-IL-1β, procaspase-1, pro-IL-18, and β-actin (E).
(F and G) THP-1-derived macrophages were stimulated with E. coli total RNA, in vitro-transcribed RNAs, or poly U plus L2K, which were pretreated with RNase mixture or were not pretreated. IL-1β and IL-18 production in the culture supernatant was measured by ELISA (F). Cell supernatants stimulated with E. coli total RNA, or in vitro-transcribed RNAs without RNase mixture pretreatment were analyzed for cleavage of IL-1β and caspase-1 by immunoblotting (G). Cell lysates were analyzed for pro-IL-1β, cleaved caspase-1, procaspase-1, pro-IL-18, and β-actin by immunoblotting (G). Values are means ± SD of at least three independent experiments. not required for inflammasome activation in human THP-1-derived macrophages.
Synthetic ssRNA Activates the Inflammasome in Human Primary
Macrophages but Not in Murine Primary Macrophages. Allen et al. (15) reported that ssRNA40, also known as "R-1075" (a U-rich ssRNA derived from the HIV-1 LTR), is sufficient to induce IL-1β secretion in human macrophages. We synthesized ssRNA40 (RNA40), 20-adenosine-ssRNA (20A), 20-uridine ssRNA (20U), 20-cytidine ssRNA (20C), and 20-guanosine ssRNA (20G) and then stimulated human MDMs and THP-1-derived macrophages with these synthetic ssRNAs. The purities of these ssRNAs were shown in Fig. S4B . We found that 20G led to the highest amount of secretion of IL-1β and IL-18 ( Fig. 6 A and C) . It also was the most effective ssRNA at cleaving IL-1β and caspase-1 in both human MDMs (Fig. 6B ) and THP-1-derived macrophages (Fig.  6D ). In contrast, 20G failed to induce IL-1β and IL-18 secretion (Fig. 6E ) and cleavage of IL-1β and caspase-1 (Fig. 6F ) in murine BMDMs. In our system, ssRNA40 did not induce inflammasome activation in human MDMs or murine BMDMs (Fig. 6 ). The ability of 20G to activate the human but not the murine inflammasome further demonstrates the differences between these two systems.
NLRP3, ASC, and Caspase-1 Are Required for Cytosolic Bacterial RNAInduced Inflammasome Activation in Human Macrophages. We investigated which inflammasome was activated by individual bacterial RNA components or synthetic 20G in THP-1-derived macrophages. Our group and others (12, 13, 21) have reported that NLPR3 mediates dsRNA-or total bacterial RNA-induced inflammasome activation. We developed specific human NLRP3-targeting, ASC-targeting, or caspase-1-targeting shRNA constructs (12) . These shRNAs for NLRP3, ASC, or caspase-1 specifically down-regulated the expression levels of the targeted proteins without affecting the expression of other proteins in THP-1-derived macrophages (Fig. 7A) . Knockdown of NLRP3, ASC, or caspase-1 in THP-1-derived macrophages predominantly abolished IL-1β in the supernatant (Fig. 7B) and completely blocked the secretion of IL-18 ( Fig. S6 ), which are induced by E. coli total RNA, in vitrotranscribed individual E. coli RNA components and synthetic 20G ssRNA. This targeting also blocked the cleavage of IL-1β and caspase-1 (Fig. 7C) , which are induced by E. coli total RNA. These observations suggest that the NLRP3/ASC/caspase-1 signaling pathway is involved in small ssRNA-induced inflammasome activation. Therefore, the NLRP3/ASC/caspase-1 inflammasome is critical for the activation of the cytosolic bacterial RNA-induced inflammasome in human macrophages.
Discussion
Recent studies have shown that human and murine innate immune cells respond differently to microbial components. Murine Toll-like receptor 7 (TLR7) and Toll-like receptor 9 (TLR9) favor sequence-specific motifs that are distinct from those efficiently recognized by human TLR7 and TLR9 (22, 23) . TLR8, which recognizes GU-rich ssRNA in humans, is nonfunctional in mice (24) . Murine myeloid cells, but not human cells, express TLR13 and recognize bacterial 23s rRNA in the endosome to activate the NF-k B pathway (25-28) Moreover, cytosolic LPS activates the caspase-11-mediated inflammasome in murine macrophages (29) . However, human cells do not have the caspase-11 gene and cannot respond to cytosolic LPS (30) . These results suggest that humans and mice have undergone major evolutionary divergence in sensing microbes. In this study, we show that human macrophages sense all bacterial RNA components (mRNA, tRNA, and rRNAs) and synthetic ssRNA to activate the NLRP3 inflammasome, whereas murine cells preferentially recognize bacterial mRNA. It is not clear how murine cells selectively recognize mRNA among the bacterial RNA components and why human macrophages can sense such a broad spectrum of cytosolic RNAs. Although tRNA and rRNAs are composed of ssRNA, they internally form a partial double-stranded secondary structure. Interestingly, Sander et al. (18) showed that the absence of 3′ polyadenylation in bacterial mRNA is the signal that activates the inflammasome. Thus, murine and human macrophages may have different sensing machinery in the NLRP3 inflammasome to distinguish a difference in structure or the presence or the absence of unique nucleic modifications among the individual bacterial RNA components.
The actual PRR that recognizes a broad spectrum of bacterial RNAs to activate NLRP3 remains poorly defined. NLRP3 responds to numerous stimuli including viral/bacterial DNA and RNA, pore-forming toxins, silica, asbestos, uric acid, ion flux, and ATP (31) . Given such a broad range of NLRP3 activators, direct binding of all these activators to NLRP3 seems unlikely. It (E and F) THP-1-derived macrophages were stimulated with poly I:C (pIC) or with E. coli total RNA plus L2K with or without heat denaturation (Heart-D) (E) or with E. coli total RNA, 5s, or 5s short rRNA (5s short) plus L2K (F). Culture supernatants were analyzed for IL-1β and IL-18 by ELISA. Values are means ± SD of at least three independent experiments.
is possible that ligand specificity can be determined by recruiting different cofactors. Our recent study showed that DHX33 triggered NLRP3-ASC-caspase-1 assembly by binding directly to dsRNA polyI:C and E. coli total RNA (12) . Further investigation is required to determine whether NLRP3 recognizes other bacterial RNA components directly or uses specific host cofactor proteins to sense a broad spectrum of the bacterial RNA components. This distinction is important, because the existence of such unique receptor/cofactors against rRNAs and tRNA in human macrophages but not in murine macrophages may explain the species difference in bacterial RNAs recognition. Recently, a number of studies have linked NLRP3 inflammasome activation to mitochondrial dysfunction. In particular, the generation of reactive oxygen species by phagocytosis or mitochondria was proposed to be critical for the activation of the NLRP3 inflammasome in response to a number of stimuli, including microbial RNAs and endogenous noncoding RNA transcripts of the Alu retrotransposon (31, 32) . Thus, it also would be interesting to investigate whether bacterial RNA-driven cellular metabolic stresses such as ion influx, lysosomal degradation, or mitochondrial dysfunction lead to inflammasome activation.
The structural requirements of bacterial RNAs and ssRNA for NLRP3-dependent caspase-1 activation in human macrophages remain elusive. The activation of the inflammasome induced by bacterial RNAs and synthetic ssRNA was mediated by NLRP3, ASC, and caspase-1 in knockdown experiments (Fig. 7) . As Sander et al. (18) reported in murine macrophages, we also found that 5′-triphosphate moieties of bacterial RNAs were dispensable for the activation of the NLRP3 inflammasome in human macrophages (Fig.  5A) . Thus, although the RIG-I-dependent inflammasome recognizes cytosolic viral-derived 5′-triphosphate RNA during infection in murine macrophages, RIG-I was not involved in bacterial RNA-induced inflammasome activation in either human or murine macrophages. It has been shown that RIG-I-and MDA-5-mediated IFN-β production is dependent on the length of the dsRNA (33) However, in our study fragmented bacterial RNA did not affect IL-1β and IL-18 production, indicating that bacterial RNA-induced inflammasome activation is length independent. The ability of digested small fragments (12-15 bps) of bacterial dsRNA, heat-denatured E. coli RNA (non-dsRNA), and synthetic singlestranded 5s short rRNA to activate the inflammasome in human macrophages suggests that the secondary structure and doublestranded structure of bacterial RNA also are dispensable for inflammasome activation. This finding also suggests that natural bacterial ssRNA can be sensed by the NLRP3-mediated inflammasome in human macrophages. The structural requirements for each bacterial RNA component to activate the NLRP3 inflammasome need further investigation.
Interestingly, only synthetic 20G ssRNA (but not 20A ssRNA, 20C ssRNA, or 20U ssRNA) efficiently triggers NLRP3-dependent inflammasome activation in human macrophages. It is known that type A oligodeoxynucleotides (CpG-A) possess poly-G tails in their sequences. The poly-G tails are capable of forming four-stranded structures known as "G-tetrads." The G-tetrad structure in CpG-A enhanced the stability of DNA and increased endosomal uptake, contributing to the production of type I IFNs in plasmacytoid dendritic cells (34, 35) . The poly-G RNA also forms intermolecular G-tetrads that result in high-molecular-weight order. This structural uniqueness of poly-G may explain why 20G ssRNA can trigger robust activation of the NLRP3-dependent inflammasome to produce IL-1β and IL-18. However, murine primary macrophages did not induce inflammasome activation in response to 20G ssRNA.
In summary, our findings demonstrate that mice and humans sense cytosolic RNA to induce NLRP3 inflammasome activation differently. Human macrophages, but not murine macrophages, sense all bacterial RNA components (mRNA, tRNA, and rRNAs) and synthetic ssRNA through NLRP3. The contribution of each bacterial RNA component to the host adaptive immune response during bacterial infection is an important question that requires further investigation. In general, NLRP3 plays an essential role in initiating the protective host inflammatory responses that limit tissue damage and overall pathogenesis during microbial infection. Thus, the identification of upstream mechanisms to activate the inflammasome in response to bacterial infection could be instrumental in developing novel therapeutics based on the specific control of the inflammasome. . (E and F) Murine BMDMs were primed with 100 ng/mL LPS for 3 h and then were stimulated with synthetic analogs or mRNA. Culture supernatants were analyzed for IL-1β and IL-18 by ELISA (E) and for cleavage of IL-1β (p17) and caspase-1 by immunoblotting (F). Cell lysates were analyzed for pro-IL-1β, procaspase-1, and β-actin (F). Values are means ± SD of at least three independent experiments. NS, nonspecific band.
Materials and Methods
All experiments with mice were approved by Baylor Institute for Immunology Research Animal Care and Use Committee and were consistent with local, state, and federal guidelines. All mice were bred in a sterile environment. Details of summary of reagents, research methods and statistical analysis are available in SI Materials and Methods. 
